Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

BACKGROUND: The management of type 2 diabetes mellitus (T2DM) in elderly population poses many challenges. Dipeptidyl peptidase-4 (DPP-4) inhibitors show particular promise due to excellent tolerability profiles, low risk of hypoglycemia, and little effect on body weight. This study evaluated, from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clinicoecon Outcomes Res
Autores principales: Permsuwan, Unchalee, Dilokthornsakul, Piyameth, Saokaew, Surasak, Thavorn, Kednapa, Chaiyakunapruk, Nathorn
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036830/
https://ncbi.nlm.nih.gov/pubmed/27703387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S113559
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares